+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Evaluation of efficacy and safety of intrabronchial specific immunotherapy with allergy medication against allergies to house mites among patients with bronchial asthma



Evaluation of efficacy and safety of intrabronchial specific immunotherapy with allergy medication against allergies to house mites among patients with bronchial asthma



Polski Merkuriusz Lekarski 6(35): 239-241



The purpose of this study was to evaluate efficacy and safety of local immunotherapy with inhaled allergens of house dust mites in asthmatic patients. An opened study was conducted in a group of 16 patients who have undergone 7 months course of immunotherapy. It has been shown statistically significant decrease in a score of clinical symptoms and in administered medications. On the other hand it has been demonstrated statistically significant increase of PEF in these patients. A decrease in specific and non-specific bronchial hyperreactivity has been revealed in bronchial provocation tests. Specific, local immunotherapy seems to be efficacious and well-tolerated way of hyposensitisation in house dust mite allergic patients.

(PDF emailed within 1 workday: $29.90)

Accession: 046009460

Download citation: RISBibTeXText

PMID: 10437390


Related references

The effect of intrabronchial specific immunotherapy on certain immunologic parameters in asthmatic patients with allergic to house mites. Polski Merkuriusz Lekarski 6(35): 236-238, 1999

The effect of local specific bronchial immunotherapy (LIT) on specific and non-specific bronchial hyperreactivity in patients with bronchial asthma sensitive to housedust mites. Polski Merkuriusz Lekarski 9(52): 645-647, 2001

Safety and efficacy of specific sublingual immunotherapy in patients with asthma and allergy to Dermatophagoides pteronyssinus. Revista Alergia Mexico 52(6): 231-236, 2006

House dust mite allergy and allergic bronchial asthma (II). Clinical aspects of house dust mite allergy and specific therapy in sensitization against house dust mites. Zfa. Zeitschrift für Allgemeinmedizin 57(13): 973-979, 1981

Safety and immunogenicity of a cluster specific immunotherapy in children with bronchial asthma and mite allergy. International Archives of Allergy and Immunology 148(3): 251-260, 2008

Efficacy and safety of specific immunotherapy of upper airways allergic diseases caused by allergy to mites. Polski Merkuriusz Lekarski 20(119): 509-513, 2006

Association Between Component-Resolved Diagnosis of House Dust Mite Allergy and Efficacy and Safety of Specific Immunotherapy. Journal of Investigational Allergology and Clinical Immunology 29(2): 164-167, 2019

Specific immunotherapy in patients with bronchial asthma hypersensitive to housedust mites. Pneumonologia i Alergologia Polska 63 Suppl 2: 42-51, 1995

Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy. Allergy 59(5): 491-497, 2004

Seasonal variability of non-specific bronchial responsiveness in asthmatic patients with allergy to house dust mites. Allergy and Asthma Proceedings 22(1): 5-9, 2001

Mites and house-dust allergy in bronchial asthma. Lancet 1(7555): 1267-1270, 1968

Efficacy and Safety of Sublingual Immunotherapy in Elderly Rhinitis Patients Sensitized to House Dust Mites. Allergy, Asthma and Immunology Research 10(6): 675-685, 2018

Humoral response in asthma patients sensitive to house dust mites during specific immunotherapy with Alutard SQ. Pneumonologia i Alergologia Polska 60 Suppl 1: 49-52, 1992

Efficacy of allergoid sublingual immunotherapy in patients with allergic bronchial asthma to house dust mite. Journal of Allergy & Clinical Immunology 113(2 Supplement): S111, 2004

Relationship between non-specific bronchial hyperreactivity and sensitization to different house dust mites in patients with asthma. Journal of Allergy & Clinical Immunology 95(1 PART 2): 268, 1995